Welcome Oskar!

We are happy to welcome Oskar Eklund to the team!

Oskar brings extensive experience in health economics and Nordic market access, with over a decade working across consultancy and the pharmaceutical industry.

He joins us from Gilead Sciences, where he led Nordic HEOR activities for products primarily in oncology and virology including ATMP/CAR-Ts.

Prior to his time at Gilead, Oskar held multiple roles at Roche and Quantify Research, where he gained broad experience in leading health economic modelling, real-world evidence, and market access projects across many therapeutic areas.

Oskar joins us as Senior Director, where his deep expertise will further strengthen our ability to deliver on our mission to advance patient access in the Nordics and to provide tailored, high-impact solutions to our clients.